SPY326.52+2.56 0.79%
DIA264.35+1.07 0.41%
IXIC10,745.28+157.46 1.49%
News
GWPH
--
0.00%
--
FDA Approves EPIDIOLEX® (cannabidiol) Oral Solution to Treat Seizures Associated with Tuberous Sclerosis Complex
GlobeNewswire · 20m ago
GW Pharmaceuticals Announces FDA Approval of EPIDIOLEX Oral Solution to Treat Seizures
Benzinga · 1h ago
GW Pharma Scores New FDA Approval For CBD Drug Epidiolex
SmarterAnalyst · 5h ago
Should Investors Buy GW Pharma Stock Right Now?
Motley Fool · 21h ago
FDA OKs new use of GW Pharma's Epidiolex
Seeking Alpha - Article · 1d ago
Top Marijuana Stocks on the NASDAQ for August 2020
Investopedia · 3d ago
Will Epidolex Drive GW Pharmaceuticals' (GWPH) Q2 Earnings?
Zacks · 3d ago
Benzinga Pro's Top 5 Stocks To Watch For Tues., Jul. 28, 2020: MCD, AAPL, SBUX, SNGX, GWPH
Today's 5 Stock Ideas:  McDonald's (MCD) - Shares were down about 2% following mixed Q2 results and global comps which were down about 24%. Apple (AAPL) - Will report Q3 results after market
Benzinga · 6d ago
The Week Ahead In Biotech: Spotlight On GW Pharma, Ultragenyx FDA Decisions, Pfizer Earnings
Biotech stocks moved lower in the week ended July 26, as the broader market weakness and sector-specific developments pressured stocks.
Benzinga · 07/26 13:55
The Week Ahead In Biotech: Spotlight On GW Pharma, Ultragenyx FDA Decisions, Pfizer Earnings
Biotech stocks moved lower in the week ended July 26, as the broader market weakness and sector-specific developments pressured stocks.Although there were promising updates from some coronavirus vaccine makers, negative headlines plagued Novavax, Inc. (NASDAQ:
Benzinga · 07/26 13:54
2 Top Pot Stocks to Buy in a Recession
In a recession, deciding on which stocks to hold in your portfolio can be a challenging task. You need to look for companies that sell products and services that will continue to be in demand during a recession and that also have reasonably priced shares (to
Motley Fool · 07/26 12:10
Stocks To Watch: Big Focus On Big Tech
Seeking Alpha · 07/25 12:26
3 Biotech Stocks With Big Incoming Catalysts
Biotech investors can get ready for a busy month full of stock-moving binary events. All of these companies are waiting for the FDA to make some very important approval decisions. Here's what you should know about three of the most important approval decisio
Motley Fool · 07/25 10:56
Cramer Weighs In On Trade Desk, DISH Network And More
On CNBC's "Mad Money Lightning Round," Jim Cramer said he likes Trade Desk Inc (NASDAQ: TTD). Although it's a wild trade, he would stick with the stock.
Benzinga · 07/24 10:55
Cramer's lightning round: Look to Raytheon and Honeywell for aerospace stocks
"Mad Money" host Jim Cramer rings the lightning round bell, which means he's giving his answers to callers' stock questions at rapid speed.
CNBC.com · 07/23 23:29
GW Pharmaceuticals plc to Report Financial Results and Operational Progress for the Second Quarter Ending June 30th, 2020 and Host Conference Call on August 6th, 2020
LONDON and CARLSBAD, Calif., July 23, 2020 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (Nasdaq: GWPH, “GW” or “the Company”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid
GlobeNewswire · 07/23 11:00
FDA releases guidelines for cannabis-related research, but CBD will have to wait
marketwatch.com · 07/23 06:42
FDA releases guidelines for cannabis-related research, but CBD will have to wait
MarketWatch · 07/21 20:09
Evercore ISI resumes best small/mid-cap ideas with 19 new names
Seeking Alpha - Article · 07/20 22:49
Better Buy: GW Pharmaceuticals vs. Corbus Pharmaceuticals
Medical marijuana is known to have helped with many health issues and has even worked better than conventional medicines in some cases. Both Cambridge, U.K.-based GW Pharmaceuticals (NASDAQ: GWPH) and Massachusetts, U.S.-based Corbus Pharmaceuticals Holdings'
Motley Fool · 07/17 20:21